Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
NCT05420597
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Laryngeal Cancer
Hypopharyngeal Cancer
Interventions
DRUG:
Toripalimab
Sponsor
Fudan University